4028 related articles for article (PubMed ID: 6112537)
1. Malignant melanoma in renal-transplant recipients.
Greene MH; Young TI; Clark WH
Lancet; 1981 May; 1(8231):1196-9. PubMed ID: 6112537
[TBL] [Abstract][Full Text] [Related]
2. Melanomas in renal transplant recipients.
Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
[TBL] [Abstract][Full Text] [Related]
3. Melanocytic naevi, melanoma and sun exposure.
Augustsson A
Acta Derm Venereol Suppl (Stockh); 1991; 166():1-34. PubMed ID: 1814137
[TBL] [Abstract][Full Text] [Related]
4. Skin surveillance of a U.K. paediatric transplant population.
Thomson MA; Suggett NR; Nightingale PG; Milford DV; Baumann U; Kelly DA; Moss C; Hill VA
Br J Dermatol; 2007 Jan; 156(1):45-50. PubMed ID: 17199565
[TBL] [Abstract][Full Text] [Related]
5. Naevi in allogeneic bone marrow transplantation recipients: the effect of graft-versus-host disease on naevi.
Andreani V; Richard MA; Blaise D; Gouvernet J; Grob JJ
Br J Dermatol; 2002 Sep; 147(3):433-41. PubMed ID: 12207581
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
[TBL] [Abstract][Full Text] [Related]
7. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
Stadler R; Garbe C
Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
9. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
Hussein MR; Elsers DA; Fadel SA; Omar AE
J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
[TBL] [Abstract][Full Text] [Related]
10. Excess benign melanocytic naevi in renal transplant recipients.
Szepietowski J; Wasik F; Szepietowski T; Włodarczyk M; Sobczak-Radwan K; Czyz W
Dermatology; 1997; 194(1):17-9. PubMed ID: 9031785
[TBL] [Abstract][Full Text] [Related]
11. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
Hussein MR
J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
13. [Melanoma in organ transplant patients].
Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
[TBL] [Abstract][Full Text] [Related]
14. [Nevus on nevus. Apropos of 7 case reports, 3 of them associated with other dysplasias, and 1 with an invasive malignant melanoma].
Brufau C; Moran M; Armijo M
Ann Dermatol Venereol; 1986; 113(5):409-18. PubMed ID: 3579111
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous malignant melanoma after Hodgkin's disease.
Tucker MA; Misfeldt D; Coleman CN; Clark WH; Rosenberg SA
Ann Intern Med; 1985 Jan; 102(1):37-41. PubMed ID: 3966743
[TBL] [Abstract][Full Text] [Related]
16. Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformation.
Fox C; Lambie D; Wilmott JS; Pinder A; Pavey S; Lê Cao KA; Akalin T; Karaarslan IK; Ozdemir F; Scolyer RA; Yamada M; Soyer HP; Schaider H; Gabrielli B
Pigment Cell Melanoma Res; 2016 Jul; 29(4):444-52. PubMed ID: 27166757
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases.
Mourmouras V; Fimiani M; Rubegni P; Epistolato MC; Malagnino V; Cardone C; Cosci E; Nisi MC; Miracco C
Br J Dermatol; 2007 Sep; 157(3):531-9. PubMed ID: 17596146
[TBL] [Abstract][Full Text] [Related]
18. [Nevus and malignant cutaneous melanoma].
Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
[TBL] [Abstract][Full Text] [Related]
19. The development of excess numbers of melanocytic naevi in an immunosuppressed identical twin.
McGregor JM; Barker JN; MacDonald DM
Clin Exp Dermatol; 1991 Mar; 16(2):131-2. PubMed ID: 2032376
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous melanoma is related to immune suppression in kidney transplant recipients.
Vajdic CM; van Leeuwen MT; Webster AC; McCredie MR; Stewart JH; Chapman JR; Amin J; McDonald SP; Grulich AE
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2297-303. PubMed ID: 19622722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
